/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
New Jersey-based Johnson & Johnson (JNJ) is a global healthcare powerhouse valued at $355.71 billion by market cap. It researches, develops, manufactures, and sells a wide range of healthcare products worldwide. Competing fiercely with other healthcare giants, one of JNJ's main rivals is Pfizer Inc. (PFE), which also has a strong presence in pharmaceuticals and consumer health.
Companies worth $200 billion or more are generally described as “mega-cap stocks,” and JNJ fits right into that category. Its market cap exceeds this threshold, reflecting its substantial size, stability, and influence in the healthcare sector. The healthcare giant has pivoted toward innovation and self-reliance through multiple acquisitions over the past years.